Jim Cramer on Regeneron Pharmaceuticals, Inc. (REGN): ‘Numbers Came Up A Little Short’

Why did UnitedHealth shares plunge over 18%? How will Walmart's tariff costs impact prices? What caused Alibaba's revenue and profit miss? Why is Dick’s Sporting Goods acquiring Foot Locker? How did Coinbase's cyberattack affect its business? What is driving Fed Chair Powell’s policy reconsideration? Why are Starbucks workers striking over dress code? How might Trump’s trade policies affect US inflation? What impact will Boeing’s Qatar deal have on aerospace?

Jim Cramer on Regeneron Pharmaceuticals, Inc. (REGN): ‘Numbers Came Up A Little Short’

finance.yahoo.com/news/jim-cramer-regeneron-pharmaceuticals-inc-144736948.html

We recently compiled a list of the 10 Jim Cramer Stocks with Huge Upside Potential. In this article, we are going to take a look at where Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) stands against the other Jim Cramer stocks with huge upside potential.
During the episode of Mad Money…

This story appeared on finance.yahoo.com, 2025-05-09 14:47:36.